Aura Biosciences, Inc.AURANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-88.80M
↓ 67% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-53.23M
Historical baseline
PeriodValueYoY Change
TTM$-88.80M-9.5%
2024$-81.06M-25.6%
2023$-64.56M-15.9%
2022$-55.70M-61.3%
2021$-34.53M-37.6%
2020$-25.09M-9.6%
2019$-22.89M-